PhD candidate Rafael Ramírez Jiménez from the ICMA – Instituto de Ciencia de Materiales de Aragón, Zaragoza, Spain spent one month, from September 14 2019 to October 14 2019, at the Institute for Medical Research and Occupational Health for his Short Term Scientific Mission application within the COST Action CA17140 NANO2CLINIC.
His STSM project was focused on understanding of the mechanism of action of nano-enabled medical agents, their enhanced biocompatibility and safety. He was trained in the Safe-by-Design approach to development of nano-enabled drug delivery system for anticancer therapy. At the same time, the NanoFaceS group benefited from his experience in the design and synthesis of nano-drug delivery agents. The mission provided the know-how necessary to provide further insight into specific aspects of medical applications of nanomaterials, in particularly for anticancer therapy by utilizing more efficient and safer-by-design nanomaterials.
